Skip to content

GeneDx Holdings WGS Income Statement

FY'25FY'24FY'23FY'22
$427.54M+40.0%$305.45M+50.8%$202.57M-13.7%$234.69M+10.6%
$129.37M+16.5%$111.05M-1.3%$112.56M-56.9%$261.44M+14.3%
$298.17M+53.4%$194.4M+116%$90.01M+436%-$26.75M-61.1%
69.7%+6.1pp63.6%+19.2pp44.4%+55.8pp-11.4%-3.6pp
$72.03M+57.5%$45.72M-21.5%$58.27M-32.4%$86.2M-18.0%
-$2.54M+16.3%-$3.03M$3.21M+13.1%
-$8.06M+72.6%-$29.42M$69.62M-65.3%
-$21.02M-$175.77M+68.0%-$548.98M-124%
-4.9%-86.8%+147pp-233.9%-118pp
$12.15M-$146.86M+75.9%-$608.34M-228%
2.8%-72.5%+187pp-259.2%-172pp
-$13.08M-$180.6M+73.0%-$667.65M-222%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are GeneDx Holdings's profit margins?
Gross margin is 69.6% and operating margin is -14.9%, with a -17.6% net margin.
Where does GeneDx Holdings's income statement data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.